Cargando…
Role of the erythropoietin receptor in Lung Cancer cells: erythropoietin exhibits angiogenic potential
Background: Recombinant human erythropoietin (rHuEPO), a hormone regulating the proliferation and differentiation of erythroid cells, is one of the prescription drugs used to treat cancer-associated anemia. However, administration of rHuEPO to cancer patients has been reported to be associated with...
Autores principales: | Liu, Xiaoqing, Tufman, Amanda, Behr, Juergen, Kiefl, Rosemarie, Goldmann, Torsten, Huber, Rudolf M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477424/ https://www.ncbi.nlm.nih.gov/pubmed/32922549 http://dx.doi.org/10.7150/jca.36924 |
Ejemplares similares
-
Erythropoietin and Its Angiogenic Activity
por: Kimáková, Patrícia, et al.
Publicado: (2017) -
Effect of erythropoietin on angiogenic potential of dental pulp cells
por: Gong, Qimei, et al.
Publicado: (2021) -
Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor
por: Hernández, Carolina Castillo, et al.
Publicado: (2017) -
Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma
por: Ribatti, D, et al.
Publicado: (2007) -
New insights into erythropoietin and erythropoietin receptor in laryngeal cancer tissue
por: Vukelic, Jelena, et al.
Publicado: (2021)